-
1
-
-
0035348374
-
The increase in risk factors for leishmaniasis worldwide
-
Desjeux, P. The increase in risk factors for leishmaniasis worldwide. Trans. R .Soc. Trop. Med. Hyg. 2001;95:239-243.
-
(2001)
Trans. R .Soc. Trop. Med. Hyg
, vol.95
, pp. 239-243
-
-
Desjeux, P.1
-
3
-
-
0003961250
-
-
Available at:, Accessed on April 15, 2007
-
Hsia R. Leishmaniasis. Available at: http://www.emedicine.com/emerg/ topic296.htm. Accessed on April 15, 2007.
-
Leishmaniasis
-
-
Hsia, R.1
-
5
-
-
0034304813
-
The epidemiology and control of leishmaniasis in Andean countries
-
Oct-Dec;
-
Davies CR, Reithinger R, Campbell-Lendrum D, Feliciangeli D, Borges R, Rodriguez N. The epidemiology and control of leishmaniasis in Andean countries. Cad Saude Publica. 2000 Oct-Dec; 16(4):925-950.
-
(2000)
Cad Saude Publica
, vol.16
, Issue.4
, pp. 925-950
-
-
Davies, C.R.1
Reithinger, R.2
Campbell-Lendrum, D.3
Feliciangeli, D.4
Borges, R.5
Rodriguez, N.6
-
6
-
-
0031836165
-
Epidemiologic Characterization of American Cutaneous Leishmaniasis in an Endemic Region of Eastern Venezuela
-
Jorquera A, Ledezma E, De Sousa L, Garcia A, Sanchez J, Zerpa J, Gonzalez R, O'Daly JA. Epidemiologic Characterization of American Cutaneous Leishmaniasis in an Endemic Region of Eastern Venezuela. Am. J. Trop. Med. Hyg. 1998. 58(5):589-593.
-
(1998)
Am. J. Trop. Med. Hyg
, vol.58
, Issue.5
, pp. 589-593
-
-
Jorquera, A.1
Ledezma, E.2
De Sousa, L.3
Garcia, A.4
Sanchez, J.5
Zerpa, J.6
Gonzalez, R.7
O'Daly, J.A.8
-
7
-
-
0021984740
-
Human cutaneous leishmaniasis acquired in Texas
-
Jan;
-
Gustafson TL, Reed CM, McGreevy PB, Pappas MG, Fox JC, Lawyer PG. Human cutaneous leishmaniasis acquired in Texas. Am J Trop Med Hyg. 1985 Jan;34(1):58-63.
-
(1985)
Am J Trop Med Hyg
, vol.34
, Issue.1
, pp. 58-63
-
-
Gustafson, T.L.1
Reed, C.M.2
McGreevy, P.B.3
Pappas, M.G.4
Fox, J.C.5
Lawyer, P.G.6
-
8
-
-
0042477180
-
Protozoan and helminth infection
-
Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg JM, Austen KF, eds, 4th ed. New York: McGraw-Hill
-
Farah FS, Klaus SN, Frankenburg S, Klion AD, Nutman TB. Protozoan and helminth infection. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg JM, Austen KF, eds. Dermatology in General Medicine. 4th ed. New York: McGraw-Hill, 1993: 2772-2777.
-
(1993)
Dermatology in General Medicine
, pp. 2772-2777
-
-
Farah, F.S.1
Klaus, S.N.2
Frankenburg, S.3
Klion, A.D.4
Nutman, T.B.5
-
9
-
-
10244251547
-
New world mucosal and cutaneous leishmaniasis: An emerging health problem among British travellers
-
Lawn SD, Whetham J, Chiodini PL, Kanagalingam J, Watson J, Behrens RH, Lockwood DNJ. New world mucosal and cutaneous leishmaniasis: an emerging health problem among British travellers. Q J Med. 2004 97 (12):781-788.
-
(2004)
Q J Med
, vol.97
, Issue.12
, pp. 781-788
-
-
Lawn, S.D.1
Whetham, J.2
Chiodini, P.L.3
Kanagalingam, J.4
Watson, J.5
Behrens, R.H.6
Lockwood, D.N.J.7
-
10
-
-
0033517487
-
Leishmaniasis
-
Herwaldt BL. Leishmaniasis. Lancet 1999; 354:1191-1199.
-
(1999)
Lancet
, vol.354
, pp. 1191-1199
-
-
Herwaldt, B.L.1
-
12
-
-
33646700031
-
New world cutaneous leishmaniasis in travellers
-
Schwartz E, Cristoph H, Blum J. New world cutaneous leishmaniasis in travellers. Lancet Infect Dis. 2006;6:342-349.
-
(2006)
Lancet Infect Dis
, vol.6
, pp. 342-349
-
-
Schwartz, E.1
Cristoph, H.2
Blum, J.3
-
13
-
-
0032437754
-
Recent trends in the treatment of cutaneous leishmaniasis
-
Alkhawajah A. Recent trends in the treatment of cutaneous leishmaniasis. Ann Saudi Med 1998; 18: 412-416.
-
(1998)
Ann Saudi Med
, vol.18
, pp. 412-416
-
-
Alkhawajah, A.1
-
14
-
-
0001034041
-
Rifampicin in the treatment of cutaneous leishmaniasis
-
Selim MM, Kandil E. Rifampicin in the treatment of cutaneous leishmaniasis. J Kuwait Med Assoc. 1972;6:159.
-
(1972)
J Kuwait Med Assoc
, vol.6
, pp. 159
-
-
Selim, M.M.1
Kandil, E.2
-
16
-
-
0022552395
-
Dapsone in the treatment of cutaneous leishmaniasis
-
Dogra J, Bhupender BL, Shyam NN. Dapsone in the treatment of cutaneous leishmaniasis. Int J Dermatol. 1986;25:398-400.
-
(1986)
Int J Dermatol
, vol.25
, pp. 398-400
-
-
Dogra, J.1
Bhupender, B.L.2
Shyam, N.N.3
-
17
-
-
0001799902
-
Leishmaniasis
-
Warren KS, Mahmoud AAF, editors, New York: McGraw-Hill Book Co
-
Wyler DJ, Marsden PD. Leishmaniasis. In: Warren KS, Mahmoud AAF, editors. Tropical and Geographical Medicine. New York: McGraw-Hill Book Co. 1984:270-280.
-
(1984)
Tropical and Geographical Medicine
, pp. 270-280
-
-
Wyler, D.J.1
Marsden, P.D.2
-
19
-
-
48749103075
-
-
The Sanger Centre, Accessed on April 14, 2007
-
The Sanger Centre. Sequencing projects www.sanger.ac.uk/Projects/. Accessed on April 14, 2007.
-
Sequencing projects
-
-
-
20
-
-
0026729038
-
Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies
-
Mar;
-
Herwaldt BL, Berman JD. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Am J Trop Med Hyg. 1992 Mar;46(3):296-306.
-
(1992)
Am J Trop Med Hyg
, vol.46
, Issue.3
, pp. 296-306
-
-
Herwaldt, B.L.1
Berman, J.D.2
-
21
-
-
0030248711
-
Treatment of New World cutaneous and mucosal leishmaniasis
-
Sep-Oct;
-
Berman JD. Treatment of New World cutaneous and mucosal leishmaniasis. Clin Dermatol. 1996 Sep-Oct;14(5):519-522.
-
(1996)
Clin Dermatol
, vol.14
, Issue.5
, pp. 519-522
-
-
Berman, J.D.1
-
22
-
-
0026542263
-
Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala
-
Mar;
-
Navin TR, Arana BA, Arana FE, Berman JD, Chajón JF. Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala. J Infect Dis. 1992 Mar;165(3):528-534.
-
(1992)
J Infect Dis
, vol.165
, Issue.3
, pp. 528-534
-
-
Navin, T.R.1
Arana, B.A.2
Arana, F.E.3
Berman, J.D.4
Chajón, J.F.5
-
23
-
-
15844394149
-
Comparison of meglumine antimoniate and pentamidine for peruvian cutaneous leishmaniasis
-
Feb;
-
Andersen EM, Cruz-Saldarriaga M, Llanos-Cuentas A, Luz-Cjuno M, Echevarria J, Miranda-Verastegui C, Colina O, Berman JD. Comparison of meglumine antimoniate and pentamidine for peruvian cutaneous leishmaniasis. Am J Trop Med Hyg. 2005 Feb;72(2):133-137.
-
(2005)
Am J Trop Med Hyg
, vol.72
, Issue.2
, pp. 133-137
-
-
Andersen, E.M.1
Cruz-Saldarriaga, M.2
Llanos-Cuentas, A.3
Luz-Cjuno, M.4
Echevarria, J.5
Miranda-Verastegui, C.6
Colina, O.7
Berman, J.D.8
-
24
-
-
1242307777
-
Treatment of cutaneous leishmaniasis among travellers
-
Feb;
-
Blum J, Desjeux P, Schwartz E, Beck B, Hatz C. Treatment of cutaneous leishmaniasis among travellers. J Antimicrob Chemother. 2004 Feb;53(2):158-166.
-
(2004)
J Antimicrob Chemother
, vol.53
, Issue.2
, pp. 158-166
-
-
Blum, J.1
Desjeux, P.2
Schwartz, E.3
Beck, B.4
Hatz, C.5
-
25
-
-
34247178377
-
Cutaneous leishmaniasis treatment. Travel Med
-
May;
-
Minodier P, Parola P. Cutaneous leishmaniasis treatment. Travel Med Infect Dis. 2007 May;5(3):150-158.
-
(2007)
Infect Dis
, vol.5
, Issue.3
, pp. 150-158
-
-
Minodier, P.1
Parola, P.2
-
26
-
-
33644862163
-
Management of cutaneous leishmaniasis in adults and children
-
Mars, Nov;
-
Minodier P, Noël G, Blanc P, Uters M, Retornaz K, Garnier JM. Management of cutaneous leishmaniasis in adults and children. Med Trop (Mars). 2005 Nov;65(5):487-495.
-
(2005)
Med Trop
, vol.65
, Issue.5
, pp. 487-495
-
-
Minodier, P.1
Noël, G.2
Blanc, P.3
Uters, M.4
Retornaz, K.5
Garnier, J.M.6
-
27
-
-
0034992336
-
Influence of clinical presentation on the efficacy of a short course of pentamidine in the treatment of cutaneous leishmaniasis in French Guiana
-
Jun;
-
Nacher M, Carme B, Sainte Marie D, Couppie P, Clyti E, Guibert P, Pradinaud R. Influence of clinical presentation on the efficacy of a short course of pentamidine in the treatment of cutaneous leishmaniasis in French Guiana. Ann Trop Med Parasitol. 2001 Jun;95(4):331-336.
-
(2001)
Ann Trop Med Parasitol
, vol.95
, Issue.4
, pp. 331-336
-
-
Nacher, M.1
Carme, B.2
Sainte Marie, D.3
Couppie, P.4
Clyti, E.5
Guibert, P.6
Pradinaud, R.7
-
28
-
-
0036680460
-
A randomized, double-blind study of the efficacy of a 10- or 20-day course of sodium stibogluconate for treatment of cutaneous leishmaniasis in United States military personnel
-
Aug 1;
-
Wortmann G, Miller RS, Oster C, Jackson J, Aronson N. A randomized, double-blind study of the efficacy of a 10- or 20-day course of sodium stibogluconate for treatment of cutaneous leishmaniasis in United States military personnel. Clin Infect Dis. 2002 Aug 1;35(3):261-267.
-
(2002)
Clin Infect Dis
, vol.35
, Issue.3
, pp. 261-267
-
-
Wortmann, G.1
Miller, R.S.2
Oster, C.3
Jackson, J.4
Aronson, N.5
-
29
-
-
0028204477
-
Efficacy of a short course (10 days) of high-dose meglumine antimoniate with or without interferon-gamma in treating cutaneous leishmaniasis in Guatemala
-
Mar;
-
Arana BA, Navin TR, Arana FE, Berman JD, Rosenkaimer F. Efficacy of a short course (10 days) of high-dose meglumine antimoniate with or without interferon-gamma in treating cutaneous leishmaniasis in Guatemala. Clin Infect Dis. 1994 Mar;18(3):381-384.
-
(1994)
Clin Infect Dis
, vol.18
, Issue.3
, pp. 381-384
-
-
Arana, B.A.1
Navin, T.R.2
Arana, F.E.3
Berman, J.D.4
Rosenkaimer, F.5
-
30
-
-
0031461177
-
A Low-Dose Antimony Treatment in 159 Patients with American Cutaneous Leishmaniasis: Extensive Follow-up Studies (Up to 10 Years)
-
Oliveira-Neto MP, Schubach A, Mattos M, Goncalves-Costa SC, Pirmez C. A Low-Dose Antimony Treatment in 159 Patients with American Cutaneous Leishmaniasis: Extensive Follow-up Studies (Up to 10 Years). Am. J. Trop. Med. Hyg. 1997;57(6):651-655.
-
(1997)
Am. J. Trop. Med. Hyg
, vol.57
, Issue.6
, pp. 651-655
-
-
Oliveira-Neto, M.P.1
Schubach, A.2
Mattos, M.3
Goncalves-Costa, S.C.4
Pirmez, C.5
-
31
-
-
33749161550
-
An alternative antimonial schedule to be used in cutaneous leishmaniasis when high doses of antimony are undesirable
-
Jul-Aug;
-
Oliveira-Neto MP, Mattos Mda S. An alternative antimonial schedule to be used in cutaneous leishmaniasis when high doses of antimony are undesirable. Rev Soc Bras Med Trop. 2006 Jul-Aug;39(4):323-326.
-
(2006)
Rev Soc Bras Med Trop
, vol.39
, Issue.4
, pp. 323-326
-
-
Oliveira-Neto, M.P.1
Mattos Mda, S.2
-
32
-
-
0030849038
-
Treatment of American cutaneous leishmaniasis: A comparison between low dosage (5 mg/kg/day) and high dosage (20 mg/kg/day) antimony regimens
-
Jun;
-
Oliveira-Neto MP, Schubach A, Mattos M, Gonçalves-Costa SC, Pirmez C. Treatment of American cutaneous leishmaniasis: a comparison between low dosage (5 mg/kg/day) and high dosage (20 mg/kg/day) antimony regimens. Pathol Biol. 1997 Jun;45(6):496-499.
-
(1997)
Pathol Biol
, vol.45
, Issue.6
, pp. 496-499
-
-
Oliveira-Neto, M.P.1
Schubach, A.2
Mattos, M.3
Gonçalves-Costa, S.C.4
Pirmez, C.5
-
33
-
-
0030091937
-
High and Low Doses of Antimony (Sbv) in American Cutaneous Leishmaniasis. A Five Years Follow-up Study of 15 Patients
-
Mar-Apr;
-
Oliveira-Neto MP, Schubach A, Araujo ML, Pirmez C. High and Low Doses of Antimony (Sbv) in American Cutaneous Leishmaniasis. A Five Years Follow-up Study of 15 Patients. Mem Inst Oswaldo Cruz. 1996 Mar-Apr;91(2):207-209.
-
(1996)
Mem Inst Oswaldo Cruz
, vol.91
, Issue.2
, pp. 207-209
-
-
Oliveira-Neto, M.P.1
Schubach, A.2
Araujo, M.L.3
Pirmez, C.4
-
34
-
-
0030742919
-
Intralesional therapy on American cutaneous leishmaniasis with pentavalent antimony in Rio de Janeiro, Brazil - an area of Leishmania (V.) braziliensis transmission
-
Jun;
-
Oliveira-Neto MP, Schubach A, Mattos M, da Costa SC, Pirmez C. Intralesional therapy on American cutaneous leishmaniasis with pentavalent antimony in Rio de Janeiro, Brazil - an area of Leishmania (V.) braziliensis transmission. Int J Dermatol. 1997 Jun;36(6):463-468.
-
(1997)
Int J Dermatol
, vol.36
, Issue.6
, pp. 463-468
-
-
Oliveira-Neto, M.P.1
Schubach, A.2
Mattos, M.3
da Costa, S.C.4
Pirmez, C.5
-
35
-
-
0028121743
-
Successful treatment of Colombian cutaneous leishmaniasis with four injections of pentamidine
-
Jan;
-
Soto J, Buffet P, Grogl M, Berman J. Successful treatment of Colombian cutaneous leishmaniasis with four injections of pentamidine. Am J Trop Med Hyg. 1994 Jan;50(1):107-111.
-
(1994)
Am J Trop Med Hyg
, vol.50
, Issue.1
, pp. 107-111
-
-
Soto, J.1
Buffet, P.2
Grogl, M.3
Berman, J.4
-
36
-
-
0027453134
-
Evaluation of pentamidine for the treatment of cutaneous leishmaniasis in Colombia
-
Mar;
-
Soto-Mancipe J, Grogl M, Berman JD. Evaluation of pentamidine for the treatment of cutaneous leishmaniasis in Colombia. Clin Infect Dis. 1993 Mar;16(3):417-425.
-
(1993)
Clin Infect Dis
, vol.16
, Issue.3
, pp. 417-425
-
-
Soto-Mancipe, J.1
Grogl, M.2
Berman, J.D.3
-
37
-
-
8344232260
-
Itraconazole Can be Effective in the Treatment of Sporotrichoid Leishmaniasis
-
Morelli P, Gianelli E, Calattini S, Corbellino M, Antinori S, Meroni L. Itraconazole Can be Effective in the Treatment of Sporotrichoid Leishmaniasis. J Travel Med. 2004;11:328-330.
-
(2004)
J Travel Med
, vol.11
, pp. 328-330
-
-
Morelli, P.1
Gianelli, E.2
Calattini, S.3
Corbellino, M.4
Antinori, S.5
Meroni, L.6
-
38
-
-
0022629289
-
Cutaneous Leishmaniasis from Belize - treatment with ketoconazole
-
Jan;
-
Jolliffe DS. Cutaneous Leishmaniasis from Belize - treatment with ketoconazole. Clin Exp Dermatol. 1986 Jan;11(1):62-68.
-
(1986)
Clin Exp Dermatol
, vol.11
, Issue.1
, pp. 62-68
-
-
Jolliffe, D.S.1
-
39
-
-
0022534492
-
Failure of oral ketoconazole to cure cutaneous ulcers caused by Leishmania braziliensis
-
Sep;
-
Dan M, Verner E, el-on J, Zuckerman F, Michaeli D. Failure of oral ketoconazole to cure cutaneous ulcers caused by Leishmania braziliensis. Cutis. 1986 Sep;38(3):198-199.
-
(1986)
Cutis
, vol.38
, Issue.3
, pp. 198-199
-
-
Dan, M.1
Verner, E.2
el-on, J.3
Zuckerman, F.4
Michaeli, D.5
-
40
-
-
0025038299
-
Efficacy of ketoconazole against Leishmania braziliensis panamensis cutaneous leishmaniasis
-
Aug;
-
Saenz RE, Paz H, Berman JD. Efficacy of ketoconazole against Leishmania braziliensis panamensis cutaneous leishmaniasis. Am J Med. 1990 Aug;89(2):147-155.
-
(1990)
Am J Med
, vol.89
, Issue.2
, pp. 147-155
-
-
Saenz, R.E.1
Paz, H.2
Berman, J.D.3
-
41
-
-
15744385718
-
Recent advances in antileishmanial drug development
-
Davis AJ, Kedzierski L. Recent advances in antileishmanial drug development. Curr Opin Invest Drugs. 2005;6(2):163-169.
-
(2005)
Curr Opin Invest Drugs
, vol.6
, Issue.2
, pp. 163-169
-
-
Davis, A.J.1
Kedzierski, L.2
-
42
-
-
0022965201
-
Leishmania major. Antileishmanial activity of methylbenzethonium chloride
-
El-on J, Messer G. Leishmania major. Antileishmanial activity of methylbenzethonium chloride. Am J Trop Hyg. 1986;35(6):1110-1116.
-
(1986)
Am J Trop Hyg
, vol.35
, Issue.6
, pp. 1110-1116
-
-
El-on, J.1
Messer, G.2
-
43
-
-
0035211329
-
Randomized, controlled, double-blind trial of tropical treatment of methylbenzethonium chloride ointment in Guatemala
-
Arana BA, Mendoza CE, Rizzo NR, Kroeger A. Randomized, controlled, double-blind trial of tropical treatment of methylbenzethonium chloride ointment in Guatemala. Am J Trop Med Hyg. 2001;65(5):466-470.
-
(2001)
Am J Trop Med Hyg
, vol.65
, Issue.5
, pp. 466-470
-
-
Arana, B.A.1
Mendoza, C.E.2
Rizzo, N.R.3
Kroeger, A.4
-
44
-
-
0030613801
-
Nonulcerative cutaneous leishmaniasis in Honduras fails to respond to topical paromomycin
-
Jul-Aug;
-
Neva FA, Ponce C, Ponce E, Kreutzer R, Modabber F, Olliaro P. Nonulcerative cutaneous leishmaniasis in Honduras fails to respond to topical paromomycin. Trans R Soc Trop Med Hyg. 1997 Jul-Aug;91(4):473-475.
-
(1997)
Trans R Soc Trop Med Hyg
, vol.91
, Issue.4
, pp. 473-475
-
-
Neva, F.A.1
Ponce, C.2
Ponce, E.3
Kreutzer, R.4
Modabber, F.5
Olliaro, P.6
-
45
-
-
3242707018
-
Comparison of the effectiveness of two topical Paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis
-
Jul;
-
Armijos RX, Weigel MM, Calvopina M, Mancheno M, Rodriguez R. Comparison of the effectiveness of two topical Paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis. Acta Trop. 2004 Jul;91(2):153-160.
-
(2004)
Acta Trop
, vol.91
, Issue.2
, pp. 153-160
-
-
Armijos, R.X.1
Weigel, M.M.2
Calvopina, M.3
Mancheno, M.4
Rodriguez, R.5
-
46
-
-
0031939452
-
Topical paromomycin/ methylbenzethonium chloride plus parenteral meglumine antimoniate as treatment for American cutaneous leishmaniasis: Controlled study
-
Jan;
-
Soto J, Fuya P. Herrera R, Berman J. Topical paromomycin/ methylbenzethonium chloride plus parenteral meglumine antimoniate as treatment for American cutaneous leishmaniasis: controlled study. Clin Infect Dis. 1998 Jan;26(1):56-58.
-
(1998)
Clin Infect Dis
, vol.26
, Issue.1
, pp. 56-58
-
-
Soto, J.1
Fuya, P.2
Herrera, R.3
Berman, J.4
-
47
-
-
0028891714
-
Successful treatment of New World cutaneous leishmaniasis with a combination of topical paromomycin/methylbenzethonium chloride and injectable meglumine antimoniate
-
Jan;
-
Soto J, Hernandez N, Mejia H, Grogl M, Berman J. Successful treatment of New World cutaneous leishmaniasis with a combination of topical paromomycin/methylbenzethonium chloride and injectable meglumine antimoniate. Clin Infect Dis. 1995 Jan;20(1):47-51.
-
(1995)
Clin Infect Dis
, vol.20
, Issue.1
, pp. 47-51
-
-
Soto, J.1
Hernandez, N.2
Mejia, H.3
Grogl, M.4
Berman, J.5
-
48
-
-
0032973750
-
Successful Topical Treatment of Murine Cutaneous Leishmaniasis with a Combination of Paromomycin (Aminosidine) and Gentamicin
-
Apr;
-
Grogl M, Schuster BG, Ellis WY, Berman JD. Successful Topical Treatment of Murine Cutaneous Leishmaniasis with a Combination of Paromomycin (Aminosidine) and Gentamicin. J Parasitol. 1999 Apr;85(2):354-359.
-
(1999)
J Parasitol
, vol.85
, Issue.2
, pp. 354-359
-
-
Grogl, M.1
Schuster, B.G.2
Ellis, W.Y.3
Berman, J.D.4
-
49
-
-
0036314069
-
Treatment of cutaneous leishmaniasis with a topical antileishmanial drug (WR279396): Phase 2 pilot study
-
Soto JM, Toledo JT, Gutierrez P, Arboleda M, Nicholls RS, Padilla JR, Berman JD, English CK, Grogl M. Treatment of cutaneous leishmaniasis with a topical antileishmanial drug (WR279396): Phase 2 pilot study. Am J Trop Med Hyg. 2002;66(2)147-151.
-
(2002)
Am J Trop Med Hyg
, vol.66
, Issue.2
, pp. 147-151
-
-
Soto, J.M.1
Toledo, J.T.2
Gutierrez, P.3
Arboleda, M.4
Nicholls, R.S.5
Padilla, J.R.6
Berman, J.D.7
English, C.K.8
Grogl, M.9
-
50
-
-
0027511787
-
Topical treatment of cutaneous leishmaniasis in Belize: In vitro and in vivo studies with Leishmania mexicana
-
Feb;
-
El-On J, Cawich F, Evans DA, Weinrauch L. Topical treatment of cutaneous leishmaniasis in Belize: in vitro and in vivo studies with Leishmania mexicana. Int J Parasitol. 1993 Feb;23(1):121-127.
-
(1993)
Int J Parasitol
, vol.23
, Issue.1
, pp. 121-127
-
-
El-On, J.1
Cawich, F.2
Evans, D.A.3
Weinrauch, L.4
-
51
-
-
0035260916
-
Clinical picture of cutaneous leishmaniasis due to Leishmania (Leishmania) mexicana in the Yucatan peninsula, Mexico
-
Feb;
-
Andrade-Narvaez FJ, Vargas-Gonzalez A, Canto-Lara SB, Damian-Centeno AG. Clinical picture of cutaneous leishmaniasis due to Leishmania (Leishmania) mexicana in the Yucatan peninsula, Mexico. Mem Inst Oswaldo Cruz. 2001 Feb;96(2):163-167.
-
(2001)
Mem Inst Oswaldo Cruz
, vol.96
, Issue.2
, pp. 163-167
-
-
Andrade-Narvaez, F.J.1
Vargas-Gonzalez, A.2
Canto-Lara, S.B.3
Damian-Centeno, A.G.4
-
52
-
-
33947168317
-
Liposomal amphotericin B in comparison to sodium stibogluconate for cutaneous infection due to Leishmania braziliensis
-
Apr;
-
Solomon M, Baum S, Barzilai A, Scope A, Trau H, Schwartz E. Liposomal amphotericin B in comparison to sodium stibogluconate for cutaneous infection due to Leishmania braziliensis. J Am Acad Dermatol. 2007 Apr;56(4):612-616.
-
(2007)
J Am Acad Dermatol
, vol.56
, Issue.4
, pp. 612-616
-
-
Solomon, M.1
Baum, S.2
Barzilai, A.3
Scope, A.4
Trau, H.5
Schwartz, E.6
-
53
-
-
34047224660
-
An Australian case of New World cutaneous leishmaniasis
-
Mar 19;
-
Konecny P, Stark DJ. An Australian case of New World cutaneous leishmaniasis. Med J Aust. 2007 Mar 19;186(6):315-317.
-
(2007)
Med J Aust
, vol.186
, Issue.6
, pp. 315-317
-
-
Konecny, P.1
Stark, D.J.2
-
54
-
-
22944470218
-
Successful liposomal amphotericin B treatment of Leishmania braziliensis cutaneous leishmaniasis
-
Jul;
-
Brown M, Noursadeghi M, Boyle J, Davidson RN. Successful liposomal amphotericin B treatment of Leishmania braziliensis cutaneous leishmaniasis. Br J Dermatol. 2005 Jul;153(1):203-205.
-
(2005)
Br J Dermatol
, vol.153
, Issue.1
, pp. 203-205
-
-
Brown, M.1
Noursadeghi, M.2
Boyle, J.3
Davidson, R.N.4
-
55
-
-
0023186694
-
The activity of alkylphosphocholines and related derivatives against Leishmania donovani
-
Croft SL, Neal RA, Pendergast W, Chan JH. The activity of alkylphosphocholines and related derivatives against Leishmania donovani. Biochemical Parasitol. 1987;2633-2636.
-
(1987)
Biochemical Parasitol
, pp. 2633-2636
-
-
Croft, S.L.1
Neal, R.A.2
Pendergast, W.3
Chan, J.H.4
-
57
-
-
2342538350
-
Miltefosine for new world cutaneous leishmaniasis
-
May 1;
-
Soto J, Arana BA, Toledo J, Rizzo N, Vega JC, Diaz A, Luz M, Gutierrez P, Arboleda M, Berman JD, Junge K, Engel J, Sindermann H. Miltefosine for new world cutaneous leishmaniasis. Clin Infect Dis. 2004 May 1;38(9):1266-1272.
-
(2004)
Clin Infect Dis
, vol.38
, Issue.9
, pp. 1266-1272
-
-
Soto, J.1
Arana, B.A.2
Toledo, J.3
Rizzo, N.4
Vega, J.C.5
Diaz, A.6
Luz, M.7
Gutierrez, P.8
Arboleda, M.9
Berman, J.D.10
Junge, K.11
Engel, J.12
Sindermann, H.13
-
58
-
-
33749336171
-
Treatment of New World cutaneous leishmaniasis with miltefosine
-
Dec;
-
Soto J, Berman J. Treatment of New World cutaneous leishmaniasis with miltefosine. Trans R Soc Trop Med Hyg. 2006 Dec;100 Suppl 1:S34-40.
-
(2006)
Trans R Soc Trop Med Hyg
, vol.100
, Issue.SUPPL. 1
-
-
Soto, J.1
Berman, J.2
-
59
-
-
1342308517
-
Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent
-
Oct 1;
-
Soto JT, Toledo J, Gutierrez P, Nicholls RS, Padilla J, Engel J, Fischer C, Voss A, Berman J. Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent. Clin Infect Dis. 2001 Oct 1;33(7):E57-61.
-
(2001)
Clin Infect Dis
, vol.33
, Issue.7
-
-
Soto, J.T.1
Toledo, J.2
Gutierrez, P.3
Nicholls, R.S.4
Padilla, J.5
Engel, J.6
Fischer, C.7
Voss, A.8
Berman, J.9
-
60
-
-
0344270951
-
Imiquimod Cream: A New Multipurpose Topical Therapy for Dermatology
-
Najarian DJ, English JC. Imiquimod Cream: A New Multipurpose Topical Therapy for Dermatology. P&T. 2003;28(2):122-126.
-
(2003)
P&T
, vol.28
, Issue.2
, pp. 122-126
-
-
Najarian, D.J.1
English, J.C.2
-
61
-
-
0033057209
-
Treatment of experimental leishmaniasis with the immunoregulators imiquimod and S-28463: Efficacy and mode of action
-
Jun;
-
Buates S, Matlashewski G. Treatment of experimental leishmaniasis with the immunoregulators imiquimod and S-28463: efficacy and mode of action. J Infect Dis. 1999 Jun;179(6):1485-1494.
-
(1999)
J Infect Dis
, vol.179
, Issue.6
, pp. 1485-1494
-
-
Buates, S.1
Matlashewski, G.2
-
62
-
-
18244373947
-
Randomized, double-blind clinical trial of topical imiquimod 5% with parenteral meglumine antimoniate in the treatment of cutaneous leishmaniasis in Peru
-
May 15;
-
Miranda-Verastegui C, Llianos-Cuentas A, Arevalo I, Ward BJ, Matlashewski G. Randomized, double-blind clinical trial of topical imiquimod 5% with parenteral meglumine antimoniate in the treatment of cutaneous leishmaniasis in Peru. Clin Infect Dis. 2005 May 15;40(10):1395-1403.
-
(2005)
Clin Infect Dis
, vol.40
, Issue.10
, pp. 1395-1403
-
-
Miranda-Verastegui, C.1
Llianos-Cuentas, A.2
Arevalo, I.3
Ward, B.J.4
Matlashewski, G.5
-
63
-
-
0035577828
-
Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator
-
Dec 1;
-
Arevalo I, Ward B, Miller R, Meng TC, Najar E, Alvarez E, Matlashewski G, Llanos-Cuentas A. Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator. Clin Infect Dis. 2001 Dec 1;33(11):1847-1851.
-
(2001)
Clin Infect Dis
, vol.33
, Issue.11
, pp. 1847-1851
-
-
Arevalo, I.1
Ward, B.2
Miller, R.3
Meng, T.C.4
Najar, E.5
Alvarez, E.6
Matlashewski, G.7
Llanos-Cuentas, A.8
-
64
-
-
34249890840
-
Role of Imiquimod and Parenteral Meglumine Antimoniate in the Initial Treatment of Cutaneous Leishmaniasis
-
Jun 15;
-
Arevalo I, Tulliano G, Quispe A, Spaeth G, Matlashewski G, Llanos-Cuentas A, Pollack H. Role of Imiquimod and Parenteral Meglumine Antimoniate in the Initial Treatment of Cutaneous Leishmaniasis. Clin Infect Dis. 2007 Jun 15;44(12):1549-1554.
-
(2007)
Clin Infect Dis
, vol.44
, Issue.12
, pp. 1549-1554
-
-
Arevalo, I.1
Tulliano, G.2
Quispe, A.3
Spaeth, G.4
Matlashewski, G.5
Llanos-Cuentas, A.6
Pollack, H.7
-
66
-
-
0031043418
-
Treatment of cutaneous leishmaniasis with allopurinol and stibogluconate
-
Feb;
-
Martinez S, Gonzalez M, Vernaza ME. Treatment of cutaneous leishmaniasis with allopurinol and stibogluconate. Clin Infect Dis. 1997 Feb;24(2):165-169.
-
(1997)
Clin Infect Dis
, vol.24
, Issue.2
, pp. 165-169
-
-
Martinez, S.1
Gonzalez, M.2
Vernaza, M.E.3
-
67
-
-
0026541511
-
Allopurinol in the treatment of American cutaneous leishmaniasis
-
Mar 12;
-
Martinez S, Marr JJ. Allopurinol in the treatment of American cutaneous leishmaniasis. N Engl J Med. 1992 Mar 12;326(11):741-744.
-
(1992)
N Engl J Med
, vol.326
, Issue.11
, pp. 741-744
-
-
Martinez, S.1
Marr, J.J.2
-
68
-
-
0025819951
-
Placebo controlled treatment of Ecuadorian cutaneous leishmaniasis
-
Jul;
-
Guderian RH, Chico ME, Rogers MD, Pattishal KM, Grogi M, Berman JD. Placebo controlled treatment of Ecuadorian cutaneous leishmaniasis. Am J Trop Med Hyg. 1991 Jul;45(1):92-97.
-
(1991)
Am J Trop Med Hyg
, vol.45
, Issue.1
, pp. 92-97
-
-
Guderian, R.H.1
Chico, M.E.2
Rogers, M.D.3
Pattishal, K.M.4
Grogi, M.5
Berman, J.D.6
-
69
-
-
0024349495
-
Treatment of American cutaneous leishmaniasis with orally administered allopurinol riboside
-
Jul;
-
Saenz RE, Paz HM, Johnson CM, Marr JJ, Nelson DJ, Pattishall KH, Rogers MD. Treatment of American cutaneous leishmaniasis with orally administered allopurinol riboside. J Infect Dis. 1989 Jul;160(1):153-158.
-
(1989)
J Infect Dis
, vol.160
, Issue.1
, pp. 153-158
-
-
Saenz, R.E.1
Paz, H.M.2
Johnson, C.M.3
Marr, J.J.4
Nelson, D.J.5
Pattishall, K.H.6
Rogers, M.D.7
-
70
-
-
0031049914
-
Inefficacy of allopurinol as monotherapy for Colombian cutaneous leishmaniasis. A randomized, controlled trial
-
Feb 1;
-
Velez I, Agudelo S, Hendrickx E, Puerta J, Grogl M, Modabber F, Berman J. Inefficacy of allopurinol as monotherapy for Colombian cutaneous leishmaniasis. A randomized, controlled trial. Ann Intern Med. 1997 Feb 1;126(3):232-236.
-
(1997)
Ann Intern Med
, vol.126
, Issue.3
, pp. 232-236
-
-
Velez, I.1
Agudelo, S.2
Hendrickx, E.3
Puerta, J.4
Grogl, M.5
Modabber, F.6
Berman, J.7
-
71
-
-
0027317582
-
Leishmaniases of the New World: Current concepts and implications for future research
-
July;
-
Grimaldi G Jr, Tesh RB. Leishmaniases of the New World: current concepts and implications for future research. Clin Microbiol Rev. 1993 July; 6(3): 230-250.
-
(1993)
Clin Microbiol Rev
, vol.6
, Issue.3
, pp. 230-250
-
-
Grimaldi Jr, G.1
Tesh, R.B.2
-
72
-
-
0029620397
-
Vaccines against leishmaniasis
-
Modabber F. Vaccines against leishmaniasis. Ann Trop Med Parasitol. 1995;89 Suppl 1:83.
-
(1995)
Ann Trop Med Parasitol
, vol.89
, Issue.SUPPL. 1
, pp. 83
-
-
Modabber, F.1
-
73
-
-
84882489798
-
Leishmaniasis
-
Guerrant RL, Walker DH, Weller PF, eds, 2nd ed. Philadelphia: Churchill Livinstone
-
Jeronimo SMB, de Queiroz Sousa A, Pearson RD. Leishmaniasis. In: Guerrant RL, Walker DH, Weller PF, eds. Tropical Infectious Diseases: Principles, Pathogens and Practice. 2nd ed. Philadelphia: Churchill Livinstone, 2006:1095.
-
(2006)
Tropical Infectious Diseases: Principles, Pathogens and Practice
, pp. 1095
-
-
Jeronimo, S.M.B.1
de Queiroz Sousa, A.2
Pearson, R.D.3
-
74
-
-
0037090268
-
CD8+ T Cells Are Required for Primary Immunity in C57BL/6 Mice Following Low-Dose, Intradermal Challenge with Leishmania major
-
Belkaid Y, Von Stebut E, Mendez S, Lira R, Caler E, Bertholet S, Udey MC, Sacks D. CD8+ T Cells Are Required for Primary Immunity in C57BL/6 Mice Following Low-Dose, Intradermal Challenge with Leishmania major. J Immunol. 2002;168:3992-4000.
-
(2002)
J Immunol
, vol.168
, pp. 3992-4000
-
-
Belkaid, Y.1
Von Stebut, E.2
Mendez, S.3
Lira, R.4
Caler, E.5
Bertholet, S.6
Udey, M.C.7
Sacks, D.8
-
75
-
-
0037124332
-
Vaccination with Heat-killed Leishmania Antigen or Recombinant Leishmanial Protein and CpG Oligodeoxynucleotides Induces Long-Term Memory CD4+ and CD8+ T Cell Responses and Protection Against Leishmania major Infection
-
Rhee EG, Mendez S, Shah JA, Wu CY, Kirman JR, Turon TN, Davey DF, Davis H, Klinman DM, Coler RN, Sacks DL, Seder RA. Vaccination with Heat-killed Leishmania Antigen or Recombinant Leishmanial Protein and CpG Oligodeoxynucleotides Induces Long-Term Memory CD4+ and CD8+ T Cell Responses and Protection Against Leishmania major Infection. J Exp Med. 2002;195:1565-1573.
-
(2002)
J Exp Med
, vol.195
, pp. 1565-1573
-
-
Rhee, E.G.1
Mendez, S.2
Shah, J.A.3
Wu, C.Y.4
Kirman, J.R.5
Turon, T.N.6
Davey, D.F.7
Davis, H.8
Klinman, D.M.9
Coler, R.N.10
Sacks, D.L.11
Seder, R.A.12
-
76
-
-
0035817254
-
Leishmaniasis Vaccination: Targeting the Source of Infection
-
Aug 6;
-
Reed SG. Leishmaniasis Vaccination: Targeting the Source of Infection. J Exp Med. 2001 Aug 6;194(3):F7-F9.
-
(2001)
J Exp Med
, vol.194
, Issue.3
-
-
Reed, S.G.1
|